To further verify the pro‐tumourigenic role of ZEB2‐AS1 and to explore the therapeutic potential of ZEB2‐AS1 targeting in HNSCC, we established HNSCC xenograft tumour models using FaDu cell inoculated into left flanks of nude mice. This evidence concerns the gene ZEB2 and head and neck squamous cell carcinoma.